Cancer Therapeutics and Biotherapeutics Market, By Type (Radiation Therapy, Chemotherapy, Biotherapy, Hormone Therapy and Others), By Top Selling Drugs (Avastin, Rituxan, Revlimid, Velcade, Herceptin, Opdivo, and Others), By Application (Breast Cancer, Lung Cancer, Blood Cancer, Prostate Cancer, Cervical Cancer, Melanoma, Head & Neck Cancer, and Others), By End-Users (Hospital, Consumption, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034

Market size for cancer treatments and biotherapeutics was estimated at US$ 220.7 billion in 2024 and is expected to increase at a compound annual growth rate (CAGR) of 7.9% to US$ 441.6 billion by 2034.

Therapy is the term for medical intervention intended to prevent or stop cancer. Chemotherapy, a unique medication that shrinks or kills cancer cells, is a part of cancer therapy. High-energy radiation is used in radiation therapy to destroy cancer cells. With hormone therapy, the cancer cells are unable to obtain the hormones required for growth. Chemotherapy for cancer employs medications that destroy cancer cells. Radiation therapy uses external beam technology. Cancer patients undergoing biotherapeutics receive treatment in which the body's immune system is used to eradicate cancer cells. Biotherapeutics are also used to stop or reduce the growth of tumors and stop cancer from spreading. Biotherapeutics seek to activate the immune system to identify and eliminate cancerous cells. Biological therapies target cancer cells by turning on and off cell signals that help them evade immune system cells, making cancer cells easier for the immune system to recognize. Immune checkpoint inhibitors are medications that block the signals that cancer cells transmit to the immune system, specifically targeting chemical receptors on cancer cells. Biological therapies also function by stimulating the immune system to fight cancer cells. This can be done by injecting chemicals that excite immune system cells into the body or by training immune system samples in a lab to attack cancer cells before they are reintroduced into the body. Hormone therapy can be administered in various ways, such as orally (as pills), intravenously (injected into muscle, arm, hip, thigh, and under the skin in fatty areas of the leg, arm, belly, etc.), or surgically (removal of the organ that produces the hormones, such as the ovaries in women and the testicles in men). On the other hand, the growing prevalence of cancer disorders has positively impacted the target market's expansion